This study used data from a large clinical database to better understand current practices in Supraventricular tachycardia (SVT) management, safety of commonly used medications, and outcomes of hospitalized infants treated for SVT. Significant variation in SVT treatment and suboptimal outcomes warrant future clinical trials to determine best practices in treating SVT in infants.